These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24414537)

  • 21. Parental ethnicity associated with risk for multiple sclerosis: A population-based incident case-control study in Iran.
    Abdollahpour I; Nedjat S; Mansournia MA; Sahraian MA; Asgari N
    Mult Scler Relat Disord; 2018 Feb; 20():100-103. PubMed ID: 29353734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis.
    Disanto G; Hall C; Lucas R; Ponsonby AL; Berlanga-Taylor AJ; Giovannoni G; Ramagopalan SV;
    Mult Scler; 2013 Sep; 19(10):1355-8. PubMed ID: 23413297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
    Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A
    Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in Ireland.
    McGuigan C; Dunne C; Crowley J; Hagan R; Rooney G; Lawlor E; Hutchinson M
    J Neurol; 2005 Oct; 252(10):1245-8. PubMed ID: 16158194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
    Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J
    Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population attributable fractions and joint effects of key risk factors for multiple sclerosis.
    van der Mei I; Lucas RM; Taylor BV; Valery PC; Dwyer T; Kilpatrick TJ; Pender MP; Williams D; Chapman C; Otahal P; Ponsonby AL
    Mult Scler; 2016 Apr; 22(4):461-9. PubMed ID: 26199349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Migration and multiple sclerosis in immigrants from United Kingdom and Ireland to Australia: a reassessment. III: risk of multiple sclerosis in UKI immigrants and Australian-born in Hobart, Tasmania.
    Barnett MH; McLeod JG; Hammond SR; Kurtzke JF
    J Neurol; 2016 Apr; 263(4):792-8. PubMed ID: 26914927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CIITA genetic polymorphism rs4774*C in combination with the HLA-DRB1*15:01 allele as a putative susceptibility factor to multiple sclerosis in Brazilian females.
    Paradela ER; Alves-Leon SV; Figueiredo AL; Pereira VC; Malfetano F; Mansur LF; Scherpenhuijzen S; Agostinho LA; Rocha CF; Rueda-Lopes F; Gasparetto E; Paiva CL
    Arq Neuropsiquiatr; 2015 Apr; 73(4):283-8. PubMed ID: 25992516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MS risk in immigrants in the McDonald era: A population-based study in Ontario, Canada.
    Rotstein DL; Marrie RA; Maxwell C; Gandhi S; Schultz SE; Fung K; Tu K
    Neurology; 2019 Dec; 93(24):e2203-e2215. PubMed ID: 31690681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple sclerosis among Afghan immigrants in Isfahan, Iran.
    Etemadifar M; Sadeghpour N; Nekouie K; Jahansouz M; Salari M; Fereidan-Esfahani M
    Mult Scler Relat Disord; 2017 Apr; 13():52-57. PubMed ID: 28427703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incorporating machine learning approaches to assess putative environmental risk factors for multiple sclerosis.
    Mowry EM; Hedström AK; Gianfrancesco MA; Shao X; Schaefer CA; Shen L; Bellesis KH; Briggs FBS; Olsson T; Alfredsson L; Barcellos LF
    Mult Scler Relat Disord; 2018 Aug; 24():135-141. PubMed ID: 30005356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).
    Kingwell E; Zhu F; Marrie RA; Fisk JD; Wolfson C; Warren S; Profetto-McGrath J; Svenson LW; Jette N; Bhan V; Yu BN; Elliott L; Tremlett H
    J Neurol; 2015 Oct; 262(10):2352-63. PubMed ID: 26205633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
    Banwell B; Bar-Or A; Arnold DL; Sadovnick D; Narayanan S; McGowan M; O'Mahony J; Magalhaes S; Hanwell H; Vieth R; Tellier R; Vincent T; Disanto G; Ebers G; Wambera K; Connolly MB; Yager J; Mah JK; Booth F; Sebire G; Callen D; Meaney B; Dilenge ME; Lortie A; Pohl D; Doja A; Venketaswaran S; Levin S; Macdonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Cooper P; Grand'maison F; Baird JB; Bhan V; Marrie RA
    Lancet Neurol; 2011 May; 10(5):436-45. PubMed ID: 21459044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis.
    Hedström AK; Sundqvist E; Bäärnhielm M; Nordin N; Hillert J; Kockum I; Olsson T; Alfredsson L
    Brain; 2011 Mar; 134(Pt 3):653-64. PubMed ID: 21303861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway.
    Smestad C; Sandvik L; Holmoy T; Harbo HF; Celius EG
    J Neurol; 2008 Jan; 255(1):49-55. PubMed ID: 18080855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.
    Bjørnevik K; Riise T; Bostrom I; Casetta I; Cortese M; Granieri E; Holmøy T; Kampman MT; Landtblom AM; Magalhaes S; Pugliatti M; Wolfson C; Myhr KM
    Mult Scler; 2017 Jun; 23(7):1018-1024. PubMed ID: 27663872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors of Multiple sclerosis and their Relation with Disease Severity: A Cross-sectional Study from Iran.
    Abbasi M; Nabavi SM; Fereshtehnejad SM; Ansari I; Zerafatjou N; Shayegannejad V; Mohammadianinejad SE; Farhoudi M; Noorian A; Razazian N; Abedini M; Faraji F
    Arch Iran Med; 2016 Dec; 19(12):852-860. PubMed ID: 27998160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA associations with multiple sclerosis in Greece.
    Kouri I; Papakonstantinou S; Bempes V; Vasiliadis HS; Kyritsis AP; Pelidou SH
    J Neurol Sci; 2011 Sep; 308(1-2):28-31. PubMed ID: 21741664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of multiple sclerosis in south-western Sardinia.
    Cocco E; Sardu C; Massa R; Mamusa E; Musu L; Ferrigno P; Melis M; Montomoli C; Ferretti V; Coghe G; Fenu G; Frau J; Lorefice L; Carboni N; Contu P; Marrosu MG
    Mult Scler; 2011 Nov; 17(11):1282-9. PubMed ID: 21652610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Risk Score for Predicting Multiple Sclerosis.
    Dobson R; Ramagopalan S; Topping J; Smith P; Solanky B; Schmierer K; Chard D; Giovannoni G
    PLoS One; 2016; 11(11):e0164992. PubMed ID: 27802296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.